Get Premium to unlock powerful stock data
NAS:STRO (USA)  
Sutro Biopharma Inc logo

Sutro Biopharma Inc

$ 4.33 +0.01 (+0.23%) 04:00 PM EST
P/E:
At Loss
P/B:
0.92
Market Cap:
$ 203.22M
Enterprise V:
$ 51.58M
Volume:
332.96K
Avg Vol (2M):
737.56K
Also Trade In:
Volume:
332.96K
Market Cap $:
203.22M
PE Ratio:
At Loss
Avg Vol (2-Month):
737.56K
Enterprise Value $:
51.58M
PB Ratio:
0.92
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Sutro Biopharma Inc
NAICS : 325412 SIC : 2834
111 Oyster Point Boulevard, South San Francisco, CA, USA, 94080
Description
Sutro Biopharma Inc is clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

Financials (Next Earnings Date:2022-08-09 Est.)

STRO's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:STRO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 53.117
EPS (TTM) ($) -2.47
Beta 1.19
Volatility % 55.35
14-Day RSI 47.64
14-Day ATR ($) 0.391942
20-Day SMA ($) 4.161
12-1 Month Momentum % -76.8
52-Week Range ($) 3.33 - 23.7
Shares Outstanding (Mil) 46.93

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sutro Biopharma Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More